慢性肾脏病患者卒中的预防与治疗:证据与指南概述
综述指出慢性肾脏病与卒中、小血管病及血管性痴呆风险升高强相关,高血压、糖尿病和房颤等常见血管因素在CKD患者中更普遍。尽管普通人群卒中治疗和生存改善,CKD尤其是透析依赖患者改善滞后,且现有预防和治疗干预在肾病人群中获益证据缺乏或矛盾。本文探讨这些干预在肾病人群中的复杂性与挑战。
要点
- CKD患者卒中、小血管病和血管性痴呆风险显著增加。
- 高血压、糖尿病、房颤等常见血管因素在CKD中更普遍。
- CKD尤其透析患者卒中治疗改善滞后,干预获益证据不足或矛盾。
核心结论
- 慢性肾脏病与卒中、小血管病和血管性痴呆风险升高强相关。
- 现有卒中预防和治疗干预在肾病人群中获益证据缺乏或存在矛盾。
研究设计与样本
- 综述,探讨卒中预防和治疗干预在肾病人群中的复杂性与挑战。
主要发现
- 高血压、糖尿病和房颤等常见血管因素在CKD患者中更普遍,解释部分关联。
- 尿毒症、氧化应激、矿物质和骨异常及透析相关因素也参与风险。
- 普通人群卒中治疗和生存改善,但CKD尤其透析依赖患者改善滞后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease is strongly associated with an increased risk of stroke, small vessel disease, and vascular dementia. Common vascular factors for stroke, such as hypertension, diabetes, and atrial fibrillation, are more prevalent in patients with chronic kidney disease, accounting for this association. However, factors unique to these patients, such as uremia, oxidative stress, and mineral and bone abnormalities, as well as dialysis-related factors are also believed to contribute to risk. Despite improvements in stroke treatment and survival in the general population, the rate of improvement in patients with chronic kidney disease, especially those who are dialysis dependent, has lagged behind. There is a lack of or conflicting evidence that those with renal disease, particularly when advanced or older, consistently derive benefit from currently available preventive and therapeutic interventions for stroke in the general population. In this review, we explore the complexities and challenges of these interventions in the population with renal disease.
引用
- Kelly DM, Rothwell PM. Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines. Kidney Int. 2019. PMID: 31866114. doi:10.1016/j.kint.2019.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。